Navigation Links
Keryx Biopharmaceuticals to Present at the J.P. Morgan 27th Annual Healthcare Conference
Date:1/13/2009

Presentation Scheduled for Thursday, January 15th at 1:00PM PT

NEW YORK, Jan. 13 /PRNewswire-FirstCall/ -- Keryx Biopharmaceuticals, Inc. (Nasdaq: KERX) today announced that Michael S. Weiss, the Company's Chairman and Chief Executive Officer, is scheduled to present at the J.P. Morgan 27th Annual Healthcare Conference being held in San Francisco.

Mr. Weiss' presentation will be webcast live on Thursday, January 15th at 1:00pm PT and will be accessible from the Investor Information page of the Company's Website at http://investors.keryx.com. An archived version of the webcast will be available following the conclusion of the live presentation.

About Keryx Biopharmaceuticals, Inc.

Keryx Biopharmaceuticals is focused on the acquisition, development and commercialization of medically important, novel pharmaceutical products for the treatment of life-threatening diseases, including renal disease and cancer. Keryx is developing Zerenex(TM) (ferric citrate), an oral, iron-based compound that has the capacity to bind to phosphate and form non-absorbable complexes. Zerenex is currently in Phase 2 clinical development for the treatment of hyperphosphatemia (elevated phosphate levels) in patients with end-stage renal disease. The Company is also developing KRX-0401 (perifosine), a novel, potentially first-in-class, oral anti-cancer agent that modulates Akt, a protein in the body associated with tumor survival and growth. KRX-0401 also modulates a number of other key signal transduction pathways, including the JNK and MAPK pathways, which are pathways associated with programmed cell death, cell growth, cell differentiation and cell survival. KRX-0401 is currently in Phase 2 clinical development for multiple tumor types. The Company also has an in-licensin
'/>"/>

SOURCE Keryx Biopharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2

Related biology technology :

1. Keryx Biopharmaceuticals Notified that Nasdaq Has Extended Minimum Bid Price Rule Compliance Period
2. Keryx Biopharmaceuticals, Inc. to Hold Conference Call on Second Quarter 2008 Financial Results on Monday, August 11, at 8:30 A.M. EDT
3. Keryx Biopharmaceuticals to Present at the Jefferies & Co. Healthcare Conference
4. Keryx Biopharmaceuticals, Inc. Announces First Quarter 2008 Financial Results
5. Keryx Biopharmaceuticals, Inc. to Hold Conference Call on First Quarter 2008 Financial Results on Monday, May 12, at 8:30 A.M. EDT
6. Keryx Biopharmaceuticals to Present at the Deutsche Bank 33rd Annual Health Care Conference
7. Keryx Biopharmaceuticals Receives Nasdaq Notification
8. Keryx Biopharmaceuticals Announces Implementation of Strategic Restructuring Plan
9. Keryx Biopharmaceuticals to Present at the Cowen and Company 28th Annual Health Care Conference
10. Keryx Biopharmaceuticals Announces that SUN-MICRO Phase 3 Clinical Trial Fails to Meet Primary Efficacy Endpoint
11. Keryx Biopharmaceuticals, Inc. Announces Fourth Quarter and Year-End 2007 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2009)Alberta Centre for Advanced Micro Nano Technology Products (ACAMP) hosts, health & medical seminar, , EDMONTON, Dec. 4 /PRNewswire/ - Today ACAMP hosted a health & medical seminar, explaini
(Date:12/3/2009)DALLAS, Dec. 3 ACCESS PHARMACEUTICALS, INC. (OTC Bulletin Board: ACCP), today provided an update on its European commercial launch of MuGard, an FDA approved treatment for oral mucositis, a deb
(Date:12/3/2009)HOPKINTON, Mass., Dec. 3 Caliper Life Sciences, Inc. (Nasdaq: CALP ), a leading provider of tools and services for drug discovery and life sciences research, today introduced Living Image 4.0 softwa
(Date:12/2/2009)NEW YORK, Dec. 2 Reportlinker.com announces that a new market research report is available in its catalogue: ,, Carbondioxide Incubators - A Global Market Perspective ,, http://www.reportlinker.co
Breaking Biology Technology:Alberta companies delivering new products to the health & medical marketplace 2Access Pharmaceuticals Provides Update on MuGard Commercial Launch in Europe 2Access Pharmaceuticals Provides Update on MuGard Commercial Launch in Europe 3Access Pharmaceuticals Provides Update on MuGard Commercial Launch in Europe 4Caliper Life Sciences Launches Living Image(R) 4.0 Software 2Reportlinker Adds Carbondioxide Incubators - A Global Market Perspective 2Reportlinker Adds Carbondioxide Incubators - A Global Market Perspective 3Reportlinker Adds Carbondioxide Incubators - A Global Market Perspective 4
...the design and manufacturing of circuits at nanosc...f the frontier fields in new material science and ...these devices often is accompanied by new discover...are of extremely small dimensions. Understanding t...me has enabled researchers to study the possibilit...
...tek Biosciences,Corporation (Nasdaq: MATK ) annou...ing Canaccord Adams Healthy Living Conference bein...l in Boston, MA. Pete Buzy, CFO and,David Abramson...rn Time on,Wednesday, October 15., A live audio w...:, http://www.newswire.ca/en/webcast/viewEvent.cgi...
...sualty incidents --,such as terrorist attacks, pan...thquakes or hurricanes -- raise the life-and-death...equate to provide treatment for all who,need it. O...ators for,people requiring respiratory support., ... know that mass,casualty events could mean that:, ...
Other Biology Technology:A new material could act as a nanofridge for microchips 2Allied Healthcare Launches First of Line of Ventilators Designed to Meet Demands of Mass Casualty Incidents 2Allied Healthcare Launches First of Line of Ventilators Designed to Meet Demands of Mass Casualty Incidents 3
(Date:12/3/2009)WALL, N.J., Dec. 3 BIO-key International, Inc. (OTC Bulletin Board: BKYI), a leader in wireless public safety and finger-based biometric identification solutions, announced that a majority of its sha
(Date:12/3/2009)Contents of this message: , , Preliminary Press Conference Topics, Last Call! Press Field Trip to California Academy of Sciences museum, Attention PIOs: Sending Press Releases to Fall meeting, N
(Date:12/3/2009)Have you ever felt overly upset by a social snubbing? Your genetics, not your friends, may be at fault. , Scientists have long known that opium-like painkillers, called opioids, relieve not only phys
Breaking Biology News(10 mins):BIO-key(R) Shareholders Overwhelmingly Approve Sale of Law Enforcement Division 2BIO-key(R) Shareholders Overwhelmingly Approve Sale of Law Enforcement Division 3AGU fall meeting: Preliminary press conference topics, press pre-registration deadline 2AGU fall meeting: Preliminary press conference topics, press pre-registration deadline 3AGU fall meeting: Preliminary press conference topics, press pre-registration deadline 4AGU fall meeting: Preliminary press conference topics, press pre-registration deadline 5AGU fall meeting: Preliminary press conference topics, press pre-registration deadline 6New Insights Could Help Shield Babies From Diarrhea Bug 51939 1New Insights Could Help Shield Babies From Diarrhea Bug 51939 2Blacks Have Highest Obesity Rates in U S 51937 1Blacks Have Highest Obesity Rates in U S 51937 2Blacks Have Highest Obesity Rates in U S 51937 3Arcadian Chairman and Chief Executive Officer Robert Fahlman to Present at Focus on Healthcare Conference in New York City 51935 1
...Amsterdam, 12 November 2008. - Elsevier, a leading...formation products and services, announced today t...Life Sciences ( http://www.elsevier.com/locate/nj...ricultural Sciences (KLV), starting in 2009 with V...f Life Sciences , published since 1952, is the qua...
...A rapid, climate change-induced northern migration...s announced Tues. Nov. 11 during opening day prese...iodiversity, Ciudad de las Artes y las Ciencias, i...species of marine macroalgae spread at 50 km per d... invasive terrestrial plants. The difference may ...
...WEST LAFAYETTE, Ind. - A Purdue University researc...on of the virus that causes SARS and could lead to...SARS in 2003 led to hundreds of deaths and thousan...nt," said Arun Ghosh, the Purdue professor that le...urrently a threat, there is the concern that SARS ...
Other Biology News:Marine invasive species advance 50 km per decade, World Conference on Marine Biodiversity told 2Marine invasive species advance 50 km per decade, World Conference on Marine Biodiversity told 3Marine invasive species advance 50 km per decade, World Conference on Marine Biodiversity told 4Purdue researcher invents molecule that stops SARS 2Purdue researcher invents molecule that stops SARS 3
Mouse Oligodendrocyte Differentiation Kit from R&D Systems
Goat Anti-VAP-1 (S-13) Polyclonal Antibody, Unconjugated from Santa Cruz Biotechnology, Inc.
...atoms at the 3, 3', 4, and 4' positions. It is int...tification of Prostaglandin E2 (PGE2) by GC- or LC...looxygenase products of arachidonic acid and one o... activity influences inflammation, fertility and p...
Site-directed Mutagenesis from Exon BioSystems
Biology Products: